Group 1 - Company X plans to invest in the research and production of optical modules, focusing on ultra-low power consumption chips for high-end applications such as AI computing centers [1] - CICC is planning to absorb and merge with Dongxing Securities and Xinda Securities through a share swap, with stock trading resuming on December 18, 2025 [2] - Bona Film Group reports normal operations and has invested in multiple films for the upcoming holiday seasons, including major productions [3] Group 2 - Tongrentang clarifies it does not hold any equity or investment rights in Sichuan Health Pharmaceutical, which is associated with a product mentioned in recent reports [4] - Meike Home is planning to acquire control of Shenzhen Wandeling Technology through a combination of cash and stock issuance, with trading suspended for up to 10 days [5] - Lanhua Ketech has obtained a coal exploration license for a specific area, laying the groundwork for future mining rights [6] Group 3 - China Duty Free Group's subsidiary has signed contracts for duty-free store operations at major Shanghai airports [7] - Baida Group's stock has seen a significant increase of 61.1% in a short period, raising concerns about potential rapid declines [8] - Changyuan Power's subsidiary has successfully connected a new power generation unit to the grid, marking its commercial operation [9] Group 4 - Guangdong Construction has launched two clean energy projects, contributing to a total installed capacity of 5084.52 MW across various energy sources [10] - Shanghai Airport has signed contracts for duty-free store operations, which are expected to positively impact future revenues [11] - Aokeli's subsidiary has entered trial production for a special high-temperature resistant resin project, aligning with its strategic goals in aerospace [12] Group 5 - China Nuclear Engineering has reported cumulative revenue of 92.03 billion yuan as of November 2025 [13] - Zhaobiao Co. plans to reduce its stake by up to 3% through various trading methods [14] - Shengtai Group's major shareholder intends to reduce its stake by up to 3% [15] Group 6 - Xinyi Co. plans to reduce its stake by up to 1% due to personal asset allocation needs [16] - Nanjing Bank intends to fully redeem 49 million preferred shares on December 23, 2025 [17] - Huakai Yibai plans to repurchase shares worth between 15 million and 30 million yuan for employee incentives [18] Group 7 - China Metallurgical Group plans to repurchase A-shares worth between 1 billion and 2 billion yuan [19] - A director of Gao Neng Environment has increased his stake by purchasing 56,100 shares [20] - Jiayuan Technology's shareholders plan to transfer 3.24 million shares, representing 2.51% of the total share capital [21] Group 8 - Pubang Co. has been awarded a construction project for Xiangmi Lake Park with a bid of 333 million yuan [22] - China CRRC has signed contracts totaling approximately 53.31 billion yuan, representing 21.6% of its projected revenue for 2024 [23][24] - Pudong Construction's subsidiaries have won multiple projects totaling 1.649 billion yuan [25] Group 9 - Pingzhi Information's subsidiary has signed a 38.25 million yuan computing service contract with a telecommunications company [26]

Group 1 - CICC is planning to absorb and merge Dongxing Securities and Xinda Securities through a share swap, with trading resuming on December 18, 2025 [1] - Victory Energy's major shareholder plans to transfer 29.99% of its shares to Qiteng Robotics, with no plans for asset restructuring in the next 12 months [2] - China Metallurgical Group intends to repurchase A-shares worth 1 to 2 billion yuan at a price not exceeding 4.9 yuan per share [3] Group 2 - Boten Co. plans to acquire part of the Yifeng Yunding Fund for 1 yuan, with a commitment to fulfill a 20 million yuan capital contribution [4] - Tongyou Technology has initiated a 50 million yuan accounts receivable factoring business [5] - Gaode Infrared has received approval to issue debt financing tools totaling up to 3 billion yuan [6] Group 3 - Zhengyu Industrial's application for a private placement of A-shares has been approved by the Shanghai Stock Exchange [7] - China CRRC signed contracts totaling approximately 53.31 billion yuan, accounting for 21.6% of its projected 2024 revenue [9] - High Energy Environment's director increased his stake by purchasing 56,100 shares [10] Group 4 - Shantou Technology received approval from the CSRC for a convertible bond issuance [11] - Puyang Co. plans to use up to 900 million yuan of idle funds for entrusted wealth management [12] - Huibai New Materials has been awarded a government subsidy of 3.8 million yuan, with the first installment of 2.12 million yuan already received [13] Group 5 - Jiayuan Technology's shareholders plan to transfer 2.51% of the company's shares through a pricing inquiry [14] - Lingpai Technology's subsidiary terminated a 125 million yuan procurement contract due to market changes [15] - Juguang Technology intends to use up to 200 million yuan of idle funds for cash management [16] Group 6 - Zhongwen Media's subsidiary terminated a 200 million yuan private equity fund subscription due to market changes [17] - Zhifei Biological's modified vaccine for monkeypox has received clinical trial acceptance [19] - GeKowei's subsidiary received a government subsidy of 60 million yuan, accounting for 32.12% of the company's audited net profit [20] Group 7 - Wantai Biological's application for a clinical trial of a respiratory syncytial virus vaccine has been accepted [21] - Haitai Technology plans to increase capital in its Thai joint venture from 500,000 to 3 million Thai baht [22] - Shanghai Airport signed contracts for the transfer of duty-free store operating rights [23] Group 8 - Del Shares received approval to issue shares for the acquisition of 100% of Aizhuo Intelligent [24] - Novozymes' products have obtained EU CE IVDR certification [25] - Shibai Testing's chairman's assistant plans to increase shareholding by 8 to 12 million yuan [26] Group 9 - Huitian New Materials plans to invest approximately 97.68 million yuan in a lithium battery anode glue project [27] - Pudong Construction's subsidiaries won contracts totaling 1.649 billion yuan [29] - Acolyte's subsidiary has entered trial production for a special high-temperature resistant resin project [30] Group 10 - Pingzhi Information's subsidiary signed a 38.25 million yuan computing power service contract [31] - Tianma Technology is required to pay 5.3625 million yuan in taxes and penalties [32] - Yahon Pharmaceutical's clinical trial application for GLX002 has been approved [34]

Core Viewpoint - The company, Shibao Testing (301228.SZ), announced that its chairman's special assistant, Yin Bingkui, plans to increase his stake in the company, reflecting confidence in its long-term investment value and future development prospects [1] Group 1 - The planned increase in shareholding will be executed within six months from the date of the announcement [1] - The investment amount for the share purchase is set to be no less than RMB 8 million and no more than RMB 12 million [1] - The acquisition will be conducted through the Shenzhen Stock Exchange system, utilizing either centralized bidding or block trading methods [1]

Core Viewpoint - The company, Shibao Testing (301228.SZ), announced that its chairman's special assistant, Yin Bingkui, plans to increase his stake in the company, reflecting confidence in its long-term investment value and future development prospects [2] Summary by Relevant Sections - **Investment Plan**: The assistant plans to increase his holdings within six months from the announcement date, with an investment amount between 8 million and 12 million yuan [2] - **Method of Purchase**: The shares will be acquired through the Shenzhen Stock Exchange system, utilizing either centralized bidding or block trading methods [2] - **Price Strategy**: There is no set price range for the share purchase; the timing will depend on market conditions [2] - **Potential Risks**: The increase in holdings may face risks related to market fluctuations and the availability of funds [2]

Core Viewpoint - The company plans to increase its shareholding through a personal investment by the chairman's special assistant, indicating confidence in the company's long-term value and future prospects [1] Group 1: Shareholding Increase - The chairman's special assistant, Yin Bingkui, intends to increase the company's shares within six months from the announcement date [1] - The planned investment amount ranges from 8 million RMB to 12 million RMB [1] - The increase will be executed through the Shenzhen Stock Exchange via centralized bidding or block trading, without a set price range [1] Group 2: Commitment and Compliance - The company commits to not reducing shareholdings within six months after the increase is completed [1] - There is a promise to refrain from insider trading and sensitive period transactions during the shareholding increase [1] - The increase will not affect the company's shareholding structure or lead to changes in the controlling shareholder or actual controller [1]

Core Viewpoint - The company, Shizhi Testing (301228.SZ), announced that its chairman's special assistant, Yin Bingkui, plans to increase his shareholding in the company, reflecting confidence in its long-term investment value and future development prospects [1] Group 1 - The planned increase in shareholding will be executed within six months from the date of the announcement [1] - The amount intended for the share purchase is set to be no less than 8 million yuan and no more than 12 million yuan [1] - The acquisition will be conducted through the Shenzhen Stock Exchange system, utilizing either centralized bidding or block trading methods [1]

Core Viewpoint - The company’s chairman's special assistant, Yin Bingkui, plans to increase his shareholding in the company, reflecting confidence in its long-term investment value and future development prospects [1] Group 1: Shareholding Plan - The planned increase in shareholding will occur within six months from the announcement date [1] - The amount of the share purchase will be no less than 8 million yuan and no more than 12 million yuan, funded by personal or self-raised funds [1] - There is no set price range for the share purchase; the purchasing entity will decide based on stock price fluctuations and overall market trends [1] Group 2: Commitment and Restrictions - The share purchase plan will be implemented within six months from the announcement date, and shares acquired will not be sold for six months after the completion of the purchase [1] - During the purchase period and the statutory period, there is a commitment not to reduce the shareholding in the company [1]

实朴检测（301228）(301228.SZ)发布公告，公司董事长特别助理尹炳奎先生基于对公司长期投资价值 的认可，以及对公司未来发展前景的信心，结合对公司股票价值的合理和独立判断，计划自公告披露之 日起6个月内，以自有资金或自筹资金通过深圳证券交易所系统，采用集中竞价交易或大宗交易方式增 持公司股份，拟增持金额不低于800万元，不高于1200万元。 ...

人民财讯12月17日电，实朴检测（301228）12月17日公告，公司董事长特别助理尹炳奎拟以自有资金或 自筹资金通过深圳证券交易所系统，采用集中竞价交易或大宗交易方式增持公司股份，拟增持金额不低 于800万元，不高于1200万元，本次增持计划未设定增持股份价格区间。 ...

证券代码：301228 证券简称：实朴检测 公告编号：2025-091 尹炳奎先生保证向本公司提供的信息内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 实朴检测技术（上海）股份有限公司 关于公司员工增持公司股份计划的公告 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 1、公司董事长特别助理尹炳奎先生基于对公司长期投资价值的认可，以及 对公司未来发展前景的信心，结合对公司股票价值的合理和独立判断，计划自本 公告披露之日起 6 个月内，以自有资金或自筹资金通过深圳证券交易所系统，采 用集中竞价交易或大宗交易方式增持公司股份，拟增持金额不低于人民币 800 万元，不高于人民币 1,200 万元。 2、本次增持计划未设定增持股份价格区间，增持主体将根据结合公司股票 价格波动情况及资本市场整体趋势，择机实施增持计划。 3、相关风险提示：本次增持计划可能存在因资本市场情况发生变化，或因 增持所需资金未能及时到位等因素导致增持计划延迟实施或无法实施的风险。敬 请广大投资者注意投资风险。 实朴检测技术（上海）股份有限公司（以下简称"公司"）于近日收到尹炳 奎先生出具的《关于股份 ...